IFP MP Oriani-Ambrosini dies

Comment on this story
iol nws aug 16 Mario Oriani-Ambrosini INDEPENDENT NEWSPAPERS File photo: Late IFP MP Oriani-Ambrosini. Picture COURTNEY AFRICA

Johannesburg - Inkatha Freedom Party MP Mario Oriani-Ambrosini died on Saturday after battling cancer, his family said.

“It is with deep sadness that we, the family of Dr Mario Oriani-Ambrosini, advise of his passing in the early hours of this morning, after a long and courageous battle with terminal lung cancer,” they said in a statement.

“We wish to thank everyone who offered such tremendous support over the past 19 months.”

The family said the love and warmth shown to Oriani-Ambrosini and to them from friends was appreciated.

Oriani-Ambrosini announced last year that he had been diagnosed with stage four lung cancer.

At the time, he said his doctors did not expect him to see Christmas 2013.

Oriani-Ambrosini said he had rejected chemotherapy as a treatment option, as it would extend his life expectancy by only a few months and would cause severe side-effects. He had opted to pursue treatment based on “different science”.

In February this year, he tabled legislation to decriminalise the medical use of dagga.

Oriani-Ambrosini, who returned to the National Assembly earlier this year after months of absence, made an impassioned plea to President Jacob Zuma and his government to decriminalise “medical marijuana”. - Sapa



sign up
 
 

Comment Guidelines



  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines